LONP1 and Mthsp70 Cooperate to Promote Mitochondrial Protein Folding
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Proteomic Analysis of the Role of the Quality Control Protease LONP1 in Mitochondrial Protein Aggregation
bioRxiv preprint doi: https://doi.org/10.1101/2021.04.12.439502; this version posted April 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Proteomic analysis of the role of the quality control protease LONP1 in mitochondrial protein aggregation Karen Pollecker1, Marc Sylvester2 and Wolfgang Voos1,* 1Institute of Biochemistry and Molecular Biology (IBMB), University of Bonn, Faculty of Medicine, Nussallee 11, 53115 Bonn, Germany 2Core facility for mass spectrometry, Institute of Biochemistry and Molecular Biology (IBMB), University of Bonn, Faculty of Medicine, Nussallee 11, 53115 Bonn, Germany *Corresponding author Email: [email protected] Phone: +49-228-732426 Abbreviations: AAA+, ATPases associated with a wide variety of cellular activities; Δψ, mitochondrial membrane potential; gKD, genetic knockdown; HSP, heat shock protein; m, mature form; mt, mitochondrial; p, precursor form; PQC, protein quality control; qMS, quantitative mass spectrometry; ROS, reactive oxygen species; SILAC, stable isotope labeling with amino acids in cell culture; siRNA, small interfering RNA; TIM, preprotein translocase complex of the inner membrane; TMRE, tetramethylrhodamine; TOM, preprotein translocase complex of the outer membrane; UPRmt, mitochondrial unfolded protein response; WT, wild type. bioRxiv preprint doi: https://doi.org/10.1101/2021.04.12.439502; this version posted April 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Low Abundance of the Matrix Arm of Complex I in Mitochondria Predicts Longevity in Mice
ARTICLE Received 24 Jan 2014 | Accepted 9 Apr 2014 | Published 12 May 2014 DOI: 10.1038/ncomms4837 OPEN Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice Satomi Miwa1, Howsun Jow2, Karen Baty3, Amy Johnson1, Rafal Czapiewski1, Gabriele Saretzki1, Achim Treumann3 & Thomas von Zglinicki1 Mitochondrial function is an important determinant of the ageing process; however, the mitochondrial properties that enable longevity are not well understood. Here we show that optimal assembly of mitochondrial complex I predicts longevity in mice. Using an unbiased high-coverage high-confidence approach, we demonstrate that electron transport chain proteins, especially the matrix arm subunits of complex I, are decreased in young long-living mice, which is associated with improved complex I assembly, higher complex I-linked state 3 oxygen consumption rates and decreased superoxide production, whereas the opposite is seen in old mice. Disruption of complex I assembly reduces oxidative metabolism with concomitant increase in mitochondrial superoxide production. This is rescued by knockdown of the mitochondrial chaperone, prohibitin. Disrupted complex I assembly causes premature senescence in primary cells. We propose that lower abundance of free catalytic complex I components supports complex I assembly, efficacy of substrate utilization and minimal ROS production, enabling enhanced longevity. 1 Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. 2 Centre for Integrated Systems Biology of Ageing and Nutrition, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. 3 Newcastle University Protein and Proteome Analysis, Devonshire Building, Devonshire Terrace, Newcastle upon Tyne NE1 7RU, UK. Correspondence and requests for materials should be addressed to T.v.Z. -
Mitochondrial Lon Protease in Human Disease and Aging: Including an Etiologic Classification of Lon-Related Diseases and Disorders
UC Irvine UC Irvine Previously Published Works Title Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders. Permalink https://escholarship.org/uc/item/2pw606qk Authors Bota, Daniela A Davies, Kelvin JA Publication Date 2016-11-01 DOI 10.1016/j.freeradbiomed.2016.06.031 Peer reviewed eScholarship.org Powered by the California Digital Library University of California HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Free Radic Manuscript Author Biol Med. Author Manuscript Author manuscript; available in PMC 2016 December 24. Published in final edited form as: Free Radic Biol Med. 2016 November ; 100: 188–198. doi:10.1016/j.freeradbiomed.2016.06.031. Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders Daniela A. Botaa,* and Kelvin J.A. Daviesb,c a Department of Neurology and Chao Family Comprehensive Cancer Center, UC Irvine School of Medicine, 200 S. Manchester Ave., Suite 206, Orange, CA 92868, USA b Leonard Davis School of Gerontology of the Ethel Percy Andrus Gerontology Center, Los Angeles, CA 90089-0191, USA c Division of Molecular & Computational Biology, Department of Biological Sciences, Dornsife College of Letters, Arts, & Sciences, The University of Southern California, Los Angeles, CA 90089-0191, USA Abstract The Mitochondrial Lon protease, also called LonP1 is a product of the nuclear gene LONP1. Lon is a major regulator of mitochondrial metabolism and response to free radical damage, as well as an essential factor for the maintenance and repair of mitochondrial DNA. Lon is an ATP- stimulated protease that cycles between being bound (at the inner surface of the inner mitochondrial membrane) to the mitochondrial genome, and being released into the mitochondrial matrix where it can degrade matrix proteins. -
Defective NDUFA9 As a Novel Cause of Neonatally Fatal
Downloaded from http://jmg.bmj.com/ on September 8, 2016 - Published by group.bmj.com New loci ORIGINAL ARTICLE Defective NDUFA9 as a novel cause of neonatally fatal complex I disease B J C van den Bosch,1,2 M Gerards,1,2 W Sluiter,3 A P A Stegmann,1 E L C Jongen,1 D M E I Hellebrekers,1 R Oegema,4 E H Lambrichs,1 H Prokisch,5,6 K Danhauser,5,6 K Schoonderwoerd,4 I F M de Coo,7 H J M Smeets1,2 < An additional table is ABSTRACT patterns. Mutations in nuclear mitochondrial genes published online only. To view Background Mitochondrial disorders are associated with include genes encoding assembly factors, complex this file please visit the journal abnormalities of the oxidative phosphorylation (OXPHOS) subunits of the OXPHOS system, and genes online (http://jmg.bmj.com/ content/49/1.toc). system and cause significant morbidity and mortality in involved in mitochondrial maintenance or metab- the population. The extensive clinical and genetic olism in general.4 Mutations in different genes can 1Department of Clinical Genetics, Unit Clinical heterogeneity of these disorders due to a broad variety lead to similar phenotypes, while mutations in the Genomics, Maastricht University of mutations in several hundreds of candidate genes, same gene can give rise to different phenotypes, Medical Centre, Maastricht, The encoded by either the mitochondrial DNA (mtDNA) or illustrating the clinical and genetic heterogeneity of Netherlands 2 nuclear DNA (nDNA), impedes a straightforward genetic these diseases. Nuclear genes are likely the major School for Oncology and diagnosis. -
Dehydroepiandrosterone Induces Growth Arrest of Hepatoma Cells Via Alteration of Mitochondrial Gene Expression and Function
969-977 10/10/08 10:56 Page 969 INTERNATIONAL JOURNAL OF ONCOLOGY 33: 969-977, 2008 969 Dehydroepiandrosterone induces growth arrest of hepatoma cells via alteration of mitochondrial gene expression and function HUNG-YAO HO1*, MEI-LING CHENG1,2,4*, HSIN-YU CHIU1, SHIUE-FEN WENG1 and DANIEL TSUN-YEE CHIU1,3,4 1Graduate Institute of Medical Biotechnology and Department of Medical Biotechnology and Laboratory Science, 2Center for Gerontological Research, 3Graduate Institute of Basic Medical Sciences, Chang Gung University; 4Department of Clinical Pathology, Chang Gung Memorial Hospital, Kwei-san, Tao-yuan, Taiwan Received April 24, 2008; Accepted June 30, 2008 DOI: 10.3892/ijo_00000084 Abstract. DHEA is known to have anti-proliferative effect. sulfate form, DHEA is the most abundant steroid in human The mechanism is not completely understood. We investigated circulation. Plasma concentration of DHEA increases during the mechanism underlying DHEA-induced growth arrest of adolescence; reaches its maximum at around 25 years of age; hepatoma cells. Growth inhibition was associated with and decreases afterwards to 10% of adolescent level by the increased G6PD activity, and insensitive to reversal by age of 80 (2). DHEA is a multifunctional hormone with such mevalonate. Thus, DHEA does not act via inhibition of G6PD beneficial effects as antiobesity (3,4), hypoglycemia (4-6); and HMGR. Instead, growth stagnation was accompanied by anti-atherosclerosis (7,8), as well as anti-aging and memory- reduced expression of nucleus-encoded mitochondrial genes; enhancing effect on brain (9). It has been reported that low morphological and functional alterations of mitochondria; DHEA levels correlated with increased risks of tumorigenesis and depletion of intracellular ATP. -
Coupling Mitochondrial Respiratory Chain to Cell Death: an Essential Role of Mitochondrial Complex I in the Interferon-B and Retinoic Acid-Induced Cancer Cell Death
Cell Death and Differentiation (2007) 14, 327–337 & 2007 Nature Publishing Group All rights reserved 1350-9047/07 $30.00 www.nature.com/cdd Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-b and retinoic acid-induced cancer cell death G Huang1, Y Chen1,HLu1 and X Cao*,1 Combination of retinoic acids (RAs) and interferons (IFNs) has synergistic apoptotic effects and is used in cancer treatment. However, the underlying mechanisms remain unknown. Here, we demonstrate that mitochondrial respiratory chain (MRC) plays an essential role in the IFN-b/RA-induced cancer cell death. We found that IFN-b/RA upregulates the expression of MRC complex subunits. Mitochondrial–nuclear translocation of these subunits was not observed, but overproduction of reactive oxygen species (ROS), which causes loss of mitochondrial function, was detected upon IFN-b/RA treatment. Knockdown of GRIM-19 (gene associated with retinoid-interferon-induced mortality-19) and NDUFS3 (NADH dehydrogenase (ubiquinone) Fe-S protein 3), two subunits of MRC complex I, by siRNA in two cancer cell lines conferred resistance to IFN-b/RA-induced apoptosis and reduced ROS production. In parallel, expression of late genes induced by IFN-b/RA that are directly involved in growth inhibition and cell death was also repressed in the knockdown cells. Our data suggest that the MRC regulates IFN-b/RA-induced cell death by modulating ROS production and late gene expression. Cell Death and Differentiation (2007) 14, 327–337. -
Protection of Scaffold Protein Isu from Degradation by the Lon Protease Pim1 As a Component of Fe–S Cluster Biogenesis Regulation
M BoC | ARTICLE Protection of scaffold protein Isu from degradation by the Lon protease Pim1 as a component of Fe–S cluster biogenesis regulation Szymon J. Ciesielskia, Brenda Schilkea, Jaroslaw Marszaleka,b, and Elizabeth A. Craiga,* aDepartment of Biochemistry, University of Wisconsin–Madison, Madison, WI 53706; bIntercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Gdansk 80307, Poland ABSTRACT Iron–sulfur (Fe–S) clusters, essential protein cofactors, are assembled on the mi- Monitoring Editor tochondrial scaffold protein Isu and then transferred to recipient proteins via a multistep Thomas D. Fox process in which Isu interacts sequentially with multiple protein factors. This pathway is in Cornell University part regulated posttranslationally by modulation of the degradation of Isu, whose abundance Received: Dec 4, 2015 increases >10-fold upon perturbation of the biogenesis process. We tested a model in which Revised: Jan 22, 2016 direct interaction with protein partners protects Isu from degradation by the mitochondrial Accepted: Jan 25, 2016 Lon-type protease. Using purified components, we demonstrated that Isu is indeed a sub- strate of the Lon-type protease and that it is protected from degradation by Nfs1, the sulfur donor for Fe–S cluster assembly, as well as by Jac1, the J-protein Hsp70 cochaperone that functions in cluster transfer from Isu. Nfs1 and Jac1 variants known to be defective in interac- tion with Isu were also defective in protecting Isu from degradation. Furthermore, overpro- duction of Jac1 protected Isu from degradation in vivo, as did Nfs1. Taken together, our re- sults lead to a model of dynamic interplay between a protease and protein factors throughout the Fe–S cluster assembly and transfer process, leading to up-regulation of Isu levels under conditions when Fe–S cluster biogenesis does not meet cellular demands. -
Phosphorylation of Human TFAM in Mitochondria Impairs DNA Binding and Promotes Degradation by the AAA+ Lon Protease
Molecular Cell Article Phosphorylation of Human TFAM in Mitochondria Impairs DNA Binding and Promotes Degradation by the AAA+ Lon Protease Bin Lu,1,4,5 Jae Lee,1,5 Xiaobo Nie,1,4,5 Min Li,1 Yaroslav I. Morozov,2 Sundararajan Venkatesh,1 Daniel F. Bogenhagen,3 Dmitry Temiakov,2 and Carolyn K. Suzuki1,* 1Department of Biochemistry and Molecular Biology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA 2Department of Cell Biology, School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Stratford, NJ 08084, USA 3Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, USA 4Present address: Institute of Biophysics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical College, Wenzhou, Zhejiang 325035, PRC 5These authors contributed equally to this work *Correspondence: [email protected] http://dx.doi.org/10.1016/j.molcel.2012.10.023 SUMMARY contrast, TFAM overproduction in transgenic mice increases mtDNA content (Ekstrand et al., 2004; Larsson et al., 1998) Human mitochondrial transcription factor A (TFAM) and also ameliorates cardiac failure (Ikeuchi et al., 2005), neuro- is a high-mobility group (HMG) protein at the nexus degeneration, and age-dependent deficits in brain function of mitochondrial DNA (mtDNA) replication, transcrip- (Hokari et al., 2010). TFAM is the most abundant component tion, and inheritance. Little is known about the mech- of mitochondrial nucleoids, which are protein complexes anisms underlying its posttranslational regulation. associated with mtDNA that orchestrate genome replication, Here, we demonstrate that TFAM is phosphorylated expression, and inheritance (Bogenhagen et al., 2008, 2012; Kukat et al., 2011). -
Electron Transport Chain Activity Is a Predictor and Target for Venetoclax Sensitivity in Multiple Myeloma
ARTICLE https://doi.org/10.1038/s41467-020-15051-z OPEN Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma Richa Bajpai1,7, Aditi Sharma 1,7, Abhinav Achreja2,3, Claudia L. Edgar1, Changyong Wei1, Arusha A. Siddiqa1, Vikas A. Gupta1, Shannon M. Matulis1, Samuel K. McBrayer 4, Anjali Mittal3,5, Manali Rupji 6, Benjamin G. Barwick 1, Sagar Lonial1, Ajay K. Nooka 1, Lawrence H. Boise 1, Deepak Nagrath2,3,5 & ✉ Mala Shanmugam 1 1234567890():,; The BCL-2 antagonist venetoclax is highly effective in multiple myeloma (MM) patients exhibiting the 11;14 translocation, the mechanistic basis of which is unknown. In evaluating cellular energetics and metabolism of t(11;14) and non-t(11;14) MM, we determine that venetoclax-sensitive myeloma has reduced mitochondrial respiration. Consistent with this, low electron transport chain (ETC) Complex I and Complex II activities correlate with venetoclax sensitivity. Inhibition of Complex I, using IACS-010759, an orally bioavailable Complex I inhibitor in clinical trials, as well as succinate ubiquinone reductase (SQR) activity of Complex II, using thenoyltrifluoroacetone (TTFA) or introduction of SDHC R72C mutant, independently sensitize resistant MM to venetoclax. We demonstrate that ETC inhibition increases BCL-2 dependence and the ‘primed’ state via the ATF4-BIM/NOXA axis. Further, SQR activity correlates with venetoclax sensitivity in patient samples irrespective of t(11;14) status. Use of SQR activity in a functional-biomarker informed manner may better select for MM patients responsive to venetoclax therapy. 1 Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA. -
De Novo Duplication on Chromosome 19 Observed in Nuclear Family Displaying Neurodevelopmental Disorders
Downloaded from molecularcasestudies.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press Title: De novo duplication on chromosome 19 observed in nuclear family displaying neurodevelopmental disorders Running Title: De novo CNV on chromosome 19 Authors: Sjaarda CP1,2*, Kaiser B1,2, McNaughton AJM1,2, Hudson ML1,2, Harris-Lowe L1,3, Lou K1,2, Guerin A4, Ayub M2, Liu X1,2 Affiliations: 1 Queen's Genomics Lab at Ongwanada (QGLO), Ongwanada Resource Center, Kingston, Ontario, Canada 2 Department of Psychiatry, Queen’s University, Kingston, Ontario, Canada 3 School of Applied Science and Computing, St. Lawrence College, Kingston, Ontario, Canada 4 Division of Medical Genetics, Department of Pediatrics, Queen's University, Kingston, Ontario, Canada. * Author for correspondence Calvin P. Sjaarda, PhD Tel: (613) 548-4419 x 1200 [email protected] 1 Downloaded from molecularcasestudies.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press ABSTRACT Pleiotropy and variable expressivity have been cited to explain the seemingly distinct neurodevelopmental disorders due to a common genetic etiology within the same family. Here we present a family with a de novo 1 Mb duplication involving 18 genes on chromosome 19. Within the family there are multiple cases of neurodevelopmental disorders including: Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, Intellectual Disability, and psychiatric disease in individuals carrying this Copy Number Variant (CNV). Quantitative PCR confirmed the CNV was de novo in the mother and inherited by both sons. Whole exome sequencing did not uncover further genetic risk factors segregating within the family. Transcriptome analysis of peripheral blood demonstrated a ~1.5-fold increase in RNA transcript abundance in 12 of the 15 detected genes within the CNV region for individuals carrying the CNV compared with their non-carrier relatives. -
Mitochondrial Lon Protease in Human Disease and Aging: Including an Etiologic Classification of Lon-Related Diseases and Disorders
HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Free Radic Manuscript Author Biol Med. Author Manuscript Author manuscript; available in PMC 2016 December 24. Published in final edited form as: Free Radic Biol Med. 2016 November ; 100: 188–198. doi:10.1016/j.freeradbiomed.2016.06.031. Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disorders Daniela A. Botaa,* and Kelvin J.A. Daviesb,c a Department of Neurology and Chao Family Comprehensive Cancer Center, UC Irvine School of Medicine, 200 S. Manchester Ave., Suite 206, Orange, CA 92868, USA b Leonard Davis School of Gerontology of the Ethel Percy Andrus Gerontology Center, Los Angeles, CA 90089-0191, USA c Division of Molecular & Computational Biology, Department of Biological Sciences, Dornsife College of Letters, Arts, & Sciences, The University of Southern California, Los Angeles, CA 90089-0191, USA Abstract The Mitochondrial Lon protease, also called LonP1 is a product of the nuclear gene LONP1. Lon is a major regulator of mitochondrial metabolism and response to free radical damage, as well as an essential factor for the maintenance and repair of mitochondrial DNA. Lon is an ATP- stimulated protease that cycles between being bound (at the inner surface of the inner mitochondrial membrane) to the mitochondrial genome, and being released into the mitochondrial matrix where it can degrade matrix proteins. At least three different roles or functions have been ascribed to Lon: 1) Proteolytic digestion of oxidized proteins and the turnover of specific essential mitochondrial enzymes such as aconitase, TFAM, and StAR; 2) Mitochondrial (mt)DNA-binding protein, involved in mtDNA replication and mitogenesis; and 3) Protein chaperone, interacting with the Hsp60–mtHsp70 complex.